Tenofovir Disoproxil Fumarate Use during Pregnancy and Infant Bone Health: the Tenofovir in Pregnancy Pilot Study

Athena P. Kourtis, Jeffrey Wiener, Liming Wang, Bo Fan, John Shepherd, Lili Chen, Wei Liu, Colin W. Shepard, Marc Bulterys

The Pediatric Infectious Disease Journal · 2018 · 17 citations · 6 references

Concepts

Abstract

The effects of maternal tenofovir use on infant bone mineral content (BMC) and bone mineral density (BMD) were evaluated in a pilot study of HIV/Hepatitis B-coinfected pregnant women in China. BMD and BMC were assessed at age 6 months of life in 14 tenofovir-exposed and 13 unexposed infants. Trends toward lower BMC and BMD were observed in infants exposed to maternal tenofovir but were not statistically significant.

References

6